Fundacion Instituto Valenciano de Oncologia Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02684318
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

FIVO | Fundacion Instituto Valenciano de Oncologia | Instituto Valenciano de Oncología | Poveda, Andrés, M.D.